Searched for
UKMHRA
India-Oman CEPA kicks in June 1: What gets cheaper, which sectors gain, and key benefits explainedIndia's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...- India-Oman FTA: Your 2-minute guide on key trade dealIndia and Oman have signed a Comprehensive Economic Partnership Agreement (CEPA), marking Oman's first such pact since 2006. The agreement ...
- Veeda Clinical Research refiles DRHP with SEBICX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red Herring Prospectu...
- Gulf connect: India & Oman push Bilateral Investment Treaty, introduction of Rupay Card in OmanAl Yousef is in India now with a 48-member delegation comprising senior officials and business leaders. With forward-looking and solution-o...
- Oman to fast-track nods to Indian pharma products registered by US, UK, EuropeOman has also requested India to consider negotiating a preferential trade agreement, the commerce and industry ministry said.
- Hold Indoco Remedies, target Rs 190: ICICI DirectHold Indoco Remedies Ltd. at a price target of Rs 190.0 .
- Alkem's Taloja facility gets clean chit by UK health regulatorThe company on Tuesday announced the closure of the inspection by the UKMHRA for its its bio-equivalence facility in Taloja.
- Alkem Laboratories slips nearly 7% on receiving 8 observations from UKMHRA"The company will submit the responses within the timeline stipulated by the UKMHRA. It does not anticipate any impact on its existing regi...
- Alkem gets 8 observations from UKMHRA for Taloja plantDrug firm Alkem Laboratories today said UK health regulator has made eight observations after inspecting its manufacturing plant at Taloja,...
- Wockhardt's Chikalthana plant gets GMP certificate from UKMHRAIn a major relief to drug firm Wockhardt, its Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice cer...
- Wockhardt plunges over 8% as Q4 net profit slips to Rs 74.45 croreThe company had posted a net profit of Rs 334.76 crore in the corresponding period of the previous fiscal, Wockhardt said in a filing to th...
- Wockhardt Q4 Net plunges 78 per cent to Rs 74.45 croreThe company had posted a net profit of Rs 334.76 crore in the corresponding period of the previous fiscal, Wockhardt said in a filing to th...
- Wockhardt's Chikalthana plant hit by USFDA import restrictionsIn May, the USFDA had also issued an import alert on the company's Waluj facility which makes injectables and solid dosages.
- Wockhardt rallies 11% after UK regulator eased restrictions on Kadiya unitUKMHRA had imposed restrictions on import of medicines made at the Mumbai-based firm's unit at Kadaiya for violation of norms.
- Wockhardt may face £1 million hit due to Kadaiya unit lapsesWockhardt today said it will take a revenue hit of nearly one million pounds due to import restrictions imposed by the UK health regulator ...
- Wockhardt drops 5%, locked in lower circuit as UK health regulator withdraws certificationThe stock is now locked in lower circuit at Rs 499.30. It has lost nearly 10% in the month of October as compared to over 60% fall so far i...
- UK health regulator withdraws certification of Wockhardt unitThe impact of the same on existing business will only be known once the company receives further communication from UKMHRA, Wockhardt said.
- Lupin allots shares to foreign fundsLupin Ltd says it has alloted 783,181 equity shares upon conversion of FCCBs worth $9.60 million to foreign funds.
Load More
